Literature DB >> 2594318

The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation.

A Heimdahl1, T Mattsson, G Dahllöf, B Lönnquist, O Ringdén.   

Abstract

Before treatment of 181 patients with bone marrow transplantation (BMT) for leukemia, severe aplastic anemia, or metabolic disorders, the oral condition was examined clinically and roentgenologically. Fifty-three patients (29%) had chronic dental infections (osteitis) that needed treatment before BMT. In 10 of 181 cases (6%), BMT was postponed because of oral infections. Septicemia during the neutropenic phase was caused by oral microorganisms (alpha streptococci) in 24 of 59 (41%) patients with microbiologically proven septicemia. Septicemia with alpha streptococci was associated with graft-versus-host disease prophylaxis with methotrexate and subsequent increased frequency of oral ulcerations. No difference was observed in the frequency of reactivation of latent herpes simplex virus infection between different graft-versus-host disease prophylaxis regimens. Reactivation was more frequent in patients conditioned with total body irradiation than in patients conditioned without total body irradiation. Antiviral prophylaxis, with subsequent decreased frequency of oral herpes simplex reactivation, appeared to contribute to a low frequency of septicemia with alpha streptococci.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2594318     DOI: 10.1016/0030-4220(89)90160-6

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  13 in total

1.  B-Cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer.

Authors:  L Hou; H Sasakj; P Stashenko
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Mucositis prevention by improved dental care in acute leukemia patients.

Authors:  Milanko Djuric; Valeria Hillier-Kolarov; Aranka Belic; Ljiljana Jankovic
Journal:  Support Care Cancer       Date:  2005-07-22       Impact factor: 3.603

3.  Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.

Authors:  E R Broun; J L Wheat; P H Kneebone; K Sundblad; R A Hromas; G Tricot
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Access to oral care before hematopoietic stem cell transplantation: understand to improve.

Authors:  Marta Aparecida Alberton Nuernberg; Samir Kanaan Nabhan; Carmem Maria Sales Bonfim; Vaneuza Araújo Moreira Funke; Cassius Carvalho Torres-Pereira
Journal:  Support Care Cancer       Date:  2016-03-07       Impact factor: 3.603

5.  Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.

Authors:  P de Jong; M de Jong; E Kuijper; J van der Lelie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

6.  Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.

Authors:  B Lönnqvist; J Palmblad; P Ljungman; G Grimfors; M Järnmark; R Lerner; C Nyström-Rosander; G Oberg
Journal:  Support Care Cancer       Date:  1993-05       Impact factor: 3.603

Review 7.  Correlation of pretransplant viral serology and complications of bone marrow transplantation.

Authors:  O Ringdén
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

8.  Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome.

Authors:  A B Melkos; G Massenkeil; R Arnold; P A Reichart
Journal:  Clin Oral Investig       Date:  2003-05-24       Impact factor: 3.573

9.  Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies.

Authors:  Stuart L Goldberg; Laura Chiang; Natalya Selina; Stephanie Hamarman
Journal:  Support Care Cancer       Date:  2004-05-19       Impact factor: 3.603

10.  Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections.

Authors:  L von Konow; P A Köndell; C E Nord; A Heimdahl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.